Wip1−/−
|
Whole body |
Upregulation of autophagy-dependent cholesterol efflux through the Atm-mTOR-dependent signaling pathway inhibits lipid deposition. |
(5) |
TFEBTG
|
Macrophage |
Reverses autophagic dysfunction of plaques, enhances phagocytosis of p62-rich protein aggregates, inhibits macrophage apoptosis and pro-inflammatory IL-1b levels, thereby reducing atherosclerosis. |
(6) |
SYK−/−
|
Macrophage |
Regulation of MHC-II through enhanced autophagy to reduce IgG levels and inhibit atherosclerosis. |
(7) |
SR-BI−/−
|
Macrophage |
SR-BI deletion reduces autophagy levels by decreasing the base of TFEB, a major regulator of autophagy, and by inhibiting the recruitment of the VPS34-Beclin-1 complex. |
(8) |
LAMP-2A−/−
|
Macrophage |
Blocking the degradation of NLRP3 protein via the chaperone-mediated autophagy pathway aggravates the inflammatory response and promotes atherosclerosis |
(9) |
Arg2−/−
|
Whole body |
Knockdown of Arg2 reduces RPS6KB1 levels, enhances PRKAA signaling and aortic endothelial cell autophagy, and reduces atherosclerotic lesion formation. |
(10) |
Atg14TG
|
Macrophage |
Overexpression of ATG14 promoted the fusion of autophagic vesicles with lysosomes, promoted lipid degradation, reduced oxidized Ox-LDL-induced apoptosis and inflammatory responses, and upregulated the number of Treg cells, thereby reducing atherosclerotic lesions. |
(11) |
|
Endothelial cell |
Absence of endothelial autophagy significantly increases lipid accumulation within the vessel wall. |
(12) |
Atg7−/−
|
T cell |
Inhibition of T-cell autophagy reduced the number of CD4+, CD8+ and NKT cells, perhaps reducing atherosclerosis. |
(13) |
|
Vascular smooth muscle cells |
Impaired autophagy in SMC promotes the accumulation of debris mitochondria, leading to more oxidative stress and resulting in an unstable plaque phenotype. |
(14) |
Atg5−/−
|
Endothelial cell |
Defective endothelial cell autophagy not only inhibits the alignment of endothelial cells with the direction of blood flow, but also promotes inflammatory, apoptotic and senescent phenotypes. |
(15) |
|
Macrophage |
Inhibition of autophagy further activates NLRP3 to promote inflammation and accelerate atherosclerosis |
(16) |